...
首页> 外文期刊>Biostatistics >Estimating incremental cost-effectiveness ratios and their confidence intervals with different terminating events for survival time and costs
【24h】

Estimating incremental cost-effectiveness ratios and their confidence intervals with different terminating events for survival time and costs

机译:用生存时间和成本的不同终止事件估算增量成本效益比及其置信区间

获取原文
获取原文并翻译 | 示例
           

摘要

Cost-effectiveness analysis (CEA) is an important component of the economic evaluation of new treatment options. In many clinical and observational studies of costs, censored data pose challenges to the CEA. We consider a special situation where the terminating events for the survival time and costs are different. Traditional methods for statistical inference offer no means for dealing with censored data in these circumstances. To address this gap, we propose a new method for deriving the confidence interval for the incremental cost-effectiveness ratio. The simulation studies and real data example show that our method performs very well for some practical settings, revealing a great potential for application to actual settings in which terminating events for the survival time and costs differ.
机译:成本效益分析(CEA)是对新治疗方案进行经济评估的重要组成部分。在许多成本的临床和观察性研究中,审查数据对CEA构成了挑战。我们考虑一种特殊情况,其中生存时间和成本的终止事件是不同的。在这种情况下,传统的统计推断方法无法提供处理审查数据的方法。为了解决这一差距,我们提出了一种新的方法来推导增量成本效益比的置信区间。仿真研究和实际数据示例表明,我们的方法在某些实际设置中表现良好,显示出在实际设置中具有巨大潜力,在实际设置中,生存时间和成本的终止事件有所不同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号